Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Dec 9, 2024. (Total: 234232Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 8 (of 8 Records)

Query Trace: Dyspnea and EGFR[original query]
Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010 Oct 28 (30): 4609-15.
Johnson Faye M, Bekele B Nebiyou, Feng Lei, Wistuba Ignacio, Tang Xi Ming, Tran Hai T, Erasmus Jeremy J, Hwang Li-Ling, Takebe Naoko, Blumenschein George R, Lippman Scott M, Stewart David
Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Sep 31 (27): 3327-34.
Sequist Lecia V, Yang James Chih-Hsin, Yamamoto Nobuyuki, O'Byrne Kenneth, Hirsh Vera, Mok Tony, Geater Sarayut Lucien, Orlov Sergey, Tsai Chun-Ming, Boyer Michael, Su Wu-Chou, Bennouna Jaafar, Kato Terufumi, Gorbunova Vera, Lee Ki Hyeong, Shah Riyaz, Massey Dan, Zazulina Victoria, Shahidi Mehdi, Schuler Mart
Disease flare after EGFR tyrosine kinase inhibitor cessation predicts poor survival in patients with non-small cell lung cancer.
Pathology oncology research : POR 2013 Oct 19 (4): 833-8.
Chen Hua-Jun, Yan Hong-Hong, Yang Jin-Ji, Chen Zhi-Hong, Su Jian, Zhang Xu-Chao, Wu Yi-Lo
Clinical Features and Gene Mutations of Lung Cancer Patients 30 Years of Age or Younger.
PloS one 2015 10 (9): e0136659.
Wang Yuehong, Chen Junjun, Ding Wei, Yan Bing, Gao Qiqi, Zhou Jianyi
Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer.
Internal medicine (Tokyo, Japan) 2017 8 56 (17): 2325-2328.
Matsumoto Yoshiya, Kawaguchi Tomoya, Yamamoto Norio, Sawa Kenji, Yoshimoto Naoki, Suzumura Tomohiro, Watanabe Tetsuya, Mitsuoka Shigeki, Asai Kazuhisa, Kimura Tatsuo, Yoshimura Naruo, Kuwae Yuko, Hirata Kazu
Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice - results from the ElderTac study.
BMC cancer 2018 Mar 18 (1): 333.
Brueckl Wolfgang M, Achenbach H Jost, Ficker Joachim H, Schuette Wolfga
Clinical outcomes and radiation pneumonitis after concurrent EGFR-tyrosine kinase inhibitors and radiotherapy for unresectable stage III non-small cell lung cancer.
Thoracic cancer 2021 Jan .
Xu Kunpeng, Liang Jun, Zhang Tao, Zhou Zongmei, Chen Dongfu, Feng Qinfu, Xiao Zefen, Hui Zhouguang, Lu Jima, Wang Xin, Deng Lei, Liu Wenyang, Wang Jianyang, Zhai Yirui, Wang Jie, Bi Nan, Wang Luh
[Clinical Characteristics and Prognosis of 76 Lung Adenocarcinoma Patients ?Harboring EGFR Mutations with Pleural Effusion at Initial Diagnosis: ?A Single-center Retrospective Study].
Zhongguo fei ai za zhi = Chinese journal of lung cancer 2022 3 25 (3): 156-166.
Yin Wencheng, Zhang Hua, Gu Yangchun, Yi Fumei, Li Qian, Liu Yan'e, Yao Yanhong, Liu Zhentao, Cao Baosh
TOP